DOD Pancreatic Cancer, Idea Development Award

基金名称
DOD Pancreatic Cancer, Idea Development Award
资助机构
Army Medical Research Acquisition Activity (AMRAA)
Department of Defense (DOD)
地区
United States
研究领域
Science and Technology and other Research and Development
截止日期
Oct 03, 2024 12:00:00 AM EDT
基金规模
7360000
联系方式
Danielle Reckley Grantor Help@eBRAP.org
申请资格

Eligible Applicants:

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

基金编号
HT942524PCARPIDA
说明

The PCARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.


Significant features of the Idea Development Award:


  • Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for individuals with pancreatic cancer. The project’s impact on both pancreatic cancer research and patient care should be articulated, even if clinical impact is not an immediate outcome.


  • Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative.


  • Personnel: Personnel are considered a crucial element of the FY24 PCARP Idea Development Award. At least one member of the research team should have experience in pancreatic cancer research, as demonstrated by recent publications and funding. Inclusion of a biostatistician in the study team is encouraged.


  • Research must be based on preliminary data: Although the proposed research must have direct relevance to pancreatic cancer, the required preliminary data, which may include unpublished results from the laboratory of the Principal Investigator(s) (PI[s]), research team, or collaborators named on the application, may be from outside the pancreatic cancer research field. Research should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.


Partnering PI Option for Early-Career Investigator: The FY24 Idea Development Award mechanism is offering a higher level of funding for applications that propose to partner an experienced PI (i.e., Initiating PI, who will serve as the mentor) with an Early-Career Investigator (i.e., Partnering PI) wishing to pursue a career in pancreatic cancer research. The Initiating PI on the Idea Development Award must mentor and collaborate with the Early-Career Investigator (Partnering PI) to promote their career development in pancreatic cancer research. The Early-Career Investigator must meet the specific eligibility criteria described in Section II.C, Eligibility Information. The Initiating PI will be responsible for the majority of the administrative tasks associated with application submission. The Initiating and Partnering PIs each have different submission requirements, as described in Section II.D.2, Content and Form of the Application Submission; however, both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. If recommended for funding, each PI will be named to an individual award within the recipient organization. Projects involving convergence science partnerships are encouraged.

基金资源

Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

Oct 03, 2024 12:00:00 AM EDT

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

相关基金

MRFF – PPHRI – 2024 Survivorship Care and Collaborative Research Prioritisation Grant Opportunity
Medical Research 31-Jul-2024 $20,000,000.00
DoD Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award
Science and Technology and other Researc... Aug 01, 2024 12:00:00 AM EDT 1200000
DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
Science and Technology and other Researc... Aug 01, 2024 12:00:00 AM EDT 3400000
DOD Spinal Cord Injury Research Program Translational Research Award
Science and Technology and other Researc... Aug 30, 2024 12:00:00 AM EDT 10320000
DoD Breast Cancer, Clinical Research Extension Award
Science and Technology and other Researc... Sep 26, 2024 12:00:00 AM EDT 9300000
DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
Science and Technology and other Researc... Oct 03, 2024 12:00:00 AM EDT 17050000
DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Science and Technology and other Researc... Oct 03, 2024 12:00:00 AM EDT 58900000
NHMRC-GACD 2024: Management of Multiple Long-Term Conditions
Medical Research 8-Oct-2024 $3,000,000.00
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
Health Sep 14, 2026 12:00:00 AM EDT 500000